NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 53 filers reported holding NEXTCURE INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $138,347 | -68.3% | 93,478 | -69.8% | 0.00% | – |
| Q4 2022 | $436,739 | -52.8% | 309,744 | -7.9% | 0.00% | – |
| Q3 2022 | $925,000 | -41.9% | 336,338 | -0.8% | 0.00% | – |
| Q2 2022 | $1,593,000 | -12.1% | 339,008 | -9.1% | 0.00% | – |
| Q1 2022 | $1,813,000 | -9.3% | 373,086 | +12.0% | 0.00% | – |
| Q4 2021 | $1,999,000 | +197.0% | 333,128 | +233.6% | 0.00% | – |
| Q3 2021 | $673,000 | -28.7% | 99,862 | -15.0% | 0.00% | – |
| Q2 2021 | $944,000 | -56.1% | 117,553 | -45.3% | 0.00% | -100.0% |
| Q1 2021 | $2,152,000 | -15.1% | 215,000 | -7.6% | 0.00% | 0.0% |
| Q4 2020 | $2,536,000 | +110.5% | 232,677 | +70.0% | 0.00% | – |
| Q3 2020 | $1,205,000 | -6.1% | 136,895 | +128.8% | 0.00% | – |
| Q2 2020 | $1,283,000 | -41.7% | 59,821 | +0.9% | 0.00% | -100.0% |
| Q1 2020 | $2,199,000 | +183.0% | 59,312 | +329.9% | 0.00% | – |
| Q4 2019 | $777,000 | +256.4% | 13,797 | +95.5% | 0.00% | – |
| Q3 2019 | $218,000 | – | 7,056 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 721,302 | $4,862,000 | 2.75% |
| Sofinnova Investments, Inc. | 2,671,856 | $18,008,000 | 1.07% |
| Canaan Partners X LLC | 321,647 | $2,168,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,022,000 | 0.42% |
| Diametric Capital, LP | 76,162 | $513,000 | 0.40% |
| Lion Point Capital, LP | 300,000 | $2,022,000 | 0.38% |
| DAFNA Capital Management LLC | 183,491 | $1,237,000 | 0.33% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 217,139 | $1,464,000 | 0.25% |
| Ikarian Capital, LLC | 509,155 | $3,431,000 | 0.24% |
| Orbimed Advisors | 2,711,013 | $18,272,000 | 0.20% |